[Quick Take] Interview with Dallas Dryden, Director of Sales at PDLabs

PDLabs offers Transdermal Verapamil (TV) 15% Gel, a painless, non-invasive treatment for fibrotic tissue disorders such as Peyronie’s disease. TV 15% has been used to treat over 13,000 patients since 1998.

Peyronie’s disease is a connective tissue disorder involving the growth of fibrous plaques in the soft tissue of the penis. The condition affects as many as 1-4% of men and usually manifests itself in Caucasians above the age of 40.

The disease can cause pain, hardened, cord-like lesions, or abnormal curvature of the penis when erect. In addition, narrowing and or shortening of the penis may occur if not treated early.

Transdermal Verapamil 15% Gel is applied directly to the skin twice a day. Verapamil belongs to the class of medications known as calcium channel blockers. The gel has been designed to carry the verapamil through the skin and deliver it to the Peyronie’s plaque. The proprietary formula allows for minimal absorption into the blood, while maximizing the concentration of verapamil in the plaque and surrounding tissue.

The comments are closed.